Virbac France SAS Sustainability Profile
Virbac France SAS, a leading player in the veterinary pharmaceutical industry, is headquartered in France and operates extensively across Europe, Asia, and the Americas. Founded in 1968, Virbac has established itself as a trusted provider of innovative health solutions for pets and livestock, focusing on areas such as vaccines, anti-infectives, and dermatology. With a commitment to research and development, Virbac offers a unique range of products that cater to the specific needs of animals, ensuring their health and well-being. The company has achieved significant milestones, including a strong market position as one of the top global veterinary pharmaceutical firms. Virbac's dedication to quality and innovation continues to set it apart in the competitive landscape of animal health.
DitchCarbon Score
How does Virbac France SAS's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Virbac France SAS's score of 28 is lower than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Virbac France SAS currently does not have specific carbon emissions data available for the most recent year, as indicated by the absence of reported figures. The company is a current subsidiary of Virbac SA, which may influence its climate commitments and emissions reporting. As of now, there are no documented reduction targets or climate pledges from Virbac France SAS. The absence of specific initiatives or targets suggests that the company may still be in the early stages of formalising its climate strategy. Given the lack of direct emissions data and reduction initiatives, it is essential for Virbac France SAS to consider establishing measurable targets and reporting frameworks to align with industry standards and enhance its sustainability profile. This could include adopting Science-Based Targets Initiative (SBTi) guidelines or participating in the Carbon Disclosure Project (CDP) to improve transparency and accountability in its climate commitments. Overall, while Virbac France SAS has not yet disclosed specific emissions data or reduction targets, its relationship with Virbac SA may provide a pathway for future climate action and reporting.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2014 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|
| Scope 1 | 19,186,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 15,014,000 | - | - | - |
| Scope 3 | 6,818,000 | - | - | - |
How Carbon Intensive is Virbac France SAS's Industry?
How Carbon Intensive is Virbac France SAS's Location?
Virbac France SAS's Scope 3 Categories Breakdown
Their carbon footprint includes suppliers and value chain emissions, with Scope 3 emissions accounting for 17% of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the primary emissions source at 73% of Scope 3 emissions.
Top Scope 3 Categories
Virbac France SAS's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Virbac France SAS has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
